Mavacamten improves symptoms of shortness of breath in patients with obstructive hypertrophic cardiomyopathy (HCM): analysis of the HCM Symptom Questionnaire in the phase 3 EXPLORER trial

Back

HFA Premium Access

Mavacamten improves symptoms of shortness of breath in patients with obstructive hypertrophic cardiomyopathy (HCM): analysis of the HCM Symptom Questionnaire in the phase 3 EXPLORER trial

Session: Myocardial Disease

Topic: Hypertrophic Cardiomyopathy

Speaker: Professor S. Naidu (New York, US)

Event: Heart Failure 2021

Congress Presentation

Add to my library

About the speaker

Professor Srihari Naidu

New York (United States of America)

0 follower

7 more presentations in this session

Predictive role of myocardial fibrosis and extracellular myocardial volume in sudden cardiac death and ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy

Speaker: Mrs N. Rineiska (Minsk, BY)

Alcohol septal ablation is safe in young patients

Speaker: Doctor A. Batzner (Wurzburg, DE)

Effects of tafamidis on quantification of myocardial amyloid deposits in patients with transthyretin amyloid cardiomyopathy

Speaker: Doctor R. Rettl (Vienna, AT)

Left atrial strain in cardiac amyloidosis

Speaker: Doctor I. Fabiani (Pisa, IT)

DPD scintigraphy fails to detect transthyretin cardiac amyloidosis in Val30Met mutation carriers with early onset disease.

Speaker: Doctor A. Olivella (Barcelona, ES)

Access the full session

Myocardial Disease

Speakers: Professor S. Naidu, Mrs N. Rineiska, Doctor A. Batzner, Doctor R. Rettl, Doctor I. Fabiani...

Access

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources